Healthcare Industry News: EZ-IO
News Release - November 18, 2010
Nursing Consortium Releases Consensus Paper on the Use of Intraosseous Vascular Access for Emergent and Non-Emergent Situations
SAN ANTONIO--(Healthcare Sales & Marketing Network)-- The Consortium on Intraosseous Vascular Access for Emergent and Nonemergent Situations in Various Healthcare Settings has released a consensus paper that recommends intraosseous (IO) vascular access be considered as an alternative to peripheral or central IV access in a variety of healthcare settings.“Intraosseous access is being increasingly adopted across a wide spectrum of uses in emergent and non-emergent situations, and this consortium’s consensus further illustrates the support within the medical community of adopting IO technology to improve patient safety and care,” commented Mark Mellin, Acting President and CEO of Vidacare Corporation. Vidacare’s EZ-IO® Vascular Access System, the market leader in IO technology, is used by 90 percent of US advanced life support ambulances and over half of US Emergency Departments, as well as the US Military.
Established in 2001, Vidacare Corporation is the developer of a broad technology platform that is defining the field of intraosseous (inside the bone) medicine. Current products include the EZ-IO® Vascular Access System, the OnControl™ Bone Marrow System and the OnControl™ Bone Access System, and applications include vascular access, emergency and disaster medicine, oncology and spinal surgery. Privately held, the company is based in San Antonio, Texas, and its products are marketed in over 50 countries worldwide. www.vidacare.com
Source: Vidacare
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
